Obesity- attributable costs of absenteeism among working adults in Portugal.
Absenteeism
Cohort Studies
Costs
Obesity
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
15 05 2022
15 05 2022
Historique:
received:
07
09
2021
accepted:
25
04
2022
entrez:
15
5
2022
pubmed:
16
5
2022
medline:
20
5
2022
Statut:
epublish
Résumé
Obesity leads to poor health outcomes and may adversely affect work productivity. This study, aimed to investigate the obesity- attributable costs of absenteeism among working adults in Portugal. The study population included individuals actively working at baseline from the Epidemiology of Chronic Diseases Cohort (EpiDoC), a large Portuguese population-based prospective study. Body mass index was measured at baseline and in two follow-up interviews. Absenteeism in each wave of the EpiDoC was assessed by the question "Did you have a sick leave in the previous 12 months? yes/no", followed by "How many days did you miss work due to sickness in the previous twelve months?". Body mass index (BMI) was classified into underweight, normal weight, overweight, and obese, based on the standard World Health Organization definition. Association between obesity and absenteeism was estimated with the negative binomial regression model adjusted for BMI, chronic diseases, and lifestyle. Obesity- attributable costs were calculated using lost gross income during the time absent from work, through the human-capital approach. The EpiDoC included 4338 working adults at baseline. Of these, 15.2% were obese at the beginning of the study and 22.7% of the population had been absent from work in the last 12 months. Participants with obesity missed 66% more days at work (IRR: 1.66; CI 95%:1.13-2.44; (p = 0.009.) than those with normal weight. The odds of having been absent from work were 1.4 times higher in obese compared to non-obese individuals (CI 95%: 1.18-1.67; p < 0.01) adjusted to sex and type of work. Obese individuals missed 3.8 more days per year than those with normal weight (95%CI: 3.1-4.5). Extrapolating to the entire Portuguese working population, absenteeism due to obesity incurred an additional cost of €238 million per year. Obesity imposes a financial burden due to absenteeism in Portugal. Employers and national health regulators should seek effective ways to reduce these costs.
Sections du résumé
BACKGROUND
Obesity leads to poor health outcomes and may adversely affect work productivity. This study, aimed to investigate the obesity- attributable costs of absenteeism among working adults in Portugal.
METHODS
The study population included individuals actively working at baseline from the Epidemiology of Chronic Diseases Cohort (EpiDoC), a large Portuguese population-based prospective study. Body mass index was measured at baseline and in two follow-up interviews. Absenteeism in each wave of the EpiDoC was assessed by the question "Did you have a sick leave in the previous 12 months? yes/no", followed by "How many days did you miss work due to sickness in the previous twelve months?". Body mass index (BMI) was classified into underweight, normal weight, overweight, and obese, based on the standard World Health Organization definition. Association between obesity and absenteeism was estimated with the negative binomial regression model adjusted for BMI, chronic diseases, and lifestyle. Obesity- attributable costs were calculated using lost gross income during the time absent from work, through the human-capital approach.
RESULTS
The EpiDoC included 4338 working adults at baseline. Of these, 15.2% were obese at the beginning of the study and 22.7% of the population had been absent from work in the last 12 months. Participants with obesity missed 66% more days at work (IRR: 1.66; CI 95%:1.13-2.44; (p = 0.009.) than those with normal weight. The odds of having been absent from work were 1.4 times higher in obese compared to non-obese individuals (CI 95%: 1.18-1.67; p < 0.01) adjusted to sex and type of work. Obese individuals missed 3.8 more days per year than those with normal weight (95%CI: 3.1-4.5). Extrapolating to the entire Portuguese working population, absenteeism due to obesity incurred an additional cost of €238 million per year.
CONCLUSION
Obesity imposes a financial burden due to absenteeism in Portugal. Employers and national health regulators should seek effective ways to reduce these costs.
Identifiants
pubmed: 35568836
doi: 10.1186/s12889-022-13337-z
pii: 10.1186/s12889-022-13337-z
pmc: PMC9107744
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
978Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2022. The Author(s).
Références
Int J Obes (Lond). 2021 Aug;45(8):1790-1801
pubmed: 34158612
PLoS Med. 2020 Sep 2;17(9):e1003319
pubmed: 32877406
Am J Health Promot. 2005 Sep-Oct;20(1):45-51
pubmed: 16171161
J Occup Environ Med. 2007 Dec;49(12):1317-24
pubmed: 18231079
Eur J Health Econ. 2016 Dec;17(9):1141-1158
pubmed: 26701837
Clin Mol Hepatol. 2014 Dec;20(4):327-37
pubmed: 25548737
Ann Rheum Dis. 2010 Jan;69 Suppl 1:i89-91
pubmed: 19995754
Pharmacoeconomics. 2015 Jul;33(7):673-89
pubmed: 25471927
Lancet Public Health. 2018 Dec;3(12):e562
pubmed: 30522681
Obes Res Clin Pract. 2018 Jan - Feb;12(1):40-50
pubmed: 28916268
Am J Public Health. 2019 Jun;109(6):e1-e12
pubmed: 31067117
J Occup Environ Med. 2019 Nov;61(11):877-886
pubmed: 31425324
Prev Med. 2019 Jan;118:122-134
pubmed: 30316876
Maturitas. 2011 Jul;69(3):220-9
pubmed: 21592692
J Occup Environ Med. 2005 Dec;47(12):1227-34
pubmed: 16340703
PLoS One. 2020 May 13;15(5):e0232236
pubmed: 32401794
Obes Rev. 2008 Sep;9(5):489-500
pubmed: 18331420
Diabetes Metab Syndr Obes. 2015 Jul 22;8:327-38
pubmed: 26229497
Occup Med (Lond). 2010 Aug;60(5):362-8
pubmed: 20308262
Psychol Addict Behav. 2013 Mar;27(1):166-77
pubmed: 22905895
BMJ Open. 2017 Oct 5;7(10):e014632
pubmed: 28982806
Eur J Health Econ. 2022 Mar;23(2):177-192
pubmed: 34347176
Ann Epidemiol. 2019 Nov;39:21-25
pubmed: 31607420
World Health Organ Tech Rep Ser. 1995;854:1-452
pubmed: 8594834
SAGE Open Med. 2016 Sep 21;4:2050312116670406
pubmed: 27708778
J Occup Environ Med. 2014 Nov;56(11):1120-7
pubmed: 25376405
Eur J Public Health. 2018 Apr 1;28(2):295-300
pubmed: 29036436
BMC Res Notes. 2014 Apr 16;7:242
pubmed: 24739239
Pharmacoeconomics. 1998 Jan;13(1 Pt 1):1-7
pubmed: 10175982
Int J Epidemiol. 2018 Dec 1;47(6):1741-1742j
pubmed: 30212889
Acta Reumatol Port. 2015 Apr-Jun;40(2):110-24
pubmed: 26219965
Eur J Health Econ. 2011 Aug;12(4):345-52
pubmed: 20401679